Published: July 5, 2012

Down syndrome research hub based at CU School of Medicine 
Nationally renowned molecular biologist Tom Blumenthal, Ph.D, has been named the new executive director of the Linda Crnic Institute for Down Syndrome, headquartered at the University of Colorado School of Medicine on the CU Anschutz Medical Campus.

Blumenthal, who is leaving his post as chairman of the Molecular, Cellular and Developmental Biology (MCDB) Department at the University of Colorado Boulder, brings an impressive track record of academic management and basic science experience to his new role.

“Morally, I believe we are obligated to help people through scientific study,” Blumenthal said. “Scientifically, I am intrigued with the Crnic Institute's mission to eradicate the medical and cognitive ill effects associated with Down syndrome. Given current technological advances, I believe we have a fighting chance at delivering. My first focus will be to dramatically increase the amount of research the Crnic Institute is engaged in and to initiate a competitive Grand Challenges grant program within the University of Colorado system.”

Blumenthal is no stranger to the Crnic Institute's mission. From its inception he has served on the Crnic Institute's Scientific Advisory Board; he has belonged to the Board of Directors for the past year.